IMPC Gene variants with increased circulating fructosamine level
Total number of significant genotype-phenotype associations: 32
Gene / Allele | Zygosity | Sex | Life Stage | Phenotype | Parameter | Phenotyping Center |
P Value |
---|---|---|---|---|---|---|---|
Lepr Leprtm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
4.06×10-44 | |
Duoxa2 Duoxa2tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.66×10-22 | |
Abcb11 Abcb11tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
HMGU IMPC |
8.83×10-12 | |
Gck Gckem1(IMPC)H |
HET | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
2.17×10-10 | |
Bhlhe40 Bhlhe40tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.23×10-10 | |
Bbs5 Bbs5tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
9.99×10-10 | |
Fam53b Fam53btm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
HMGU IMPC |
2.84×10-09 | |
Rab5c Rab5ctm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.71×10-07 | |
Pkd2l2 Pkd2l2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.34×10-06 | |
D6Wsu163e D6Wsu163etm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.12×10-06 | |
Cib2 Cib2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
2.23×10-06 | |
Sirt4 Sirt4tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
4.65×10-06 | |
Gosr2 Gosr2tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
5.46×10-06 | |
Nubp2 Nubp2tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
HMGU IMPC |
5.95×10-06 | |
Scnn1b Scnn1btm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.06×10-05 | |
Glra2 Glra2tm1b(KOMP)Wtsi |
HEM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.12×10-05 | |
Setd1a Setd1atm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI MGP |
1.15×10-05 | |
Lbp Lbptm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.28×10-05 | |
Nfya NfyaGt(EUCJ0004f10)Hmgu |
HET | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI EuroPhenome |
1.68×10-05 | |
Arrdc5 Arrdc5tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
3.62×10-05 | |
Sbno1 Sbno1tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
5.23×10-05 | |
Myt1l Myt1ltm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
5.86×10-05 | |
Plac9 Plac9tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
6.28×10-05 | |
Dnajc17 Dnajc17tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
HMGU IMPC |
6.64×10-05 | |
Gsdme Gsdmetm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
6.82×10-05 | |
Irak1 Irak1tm1b(EUCOMM)Hmgu |
HEM | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
7.47×10-05 | |
Slc24a4 Slc24a4tm1b(KOMP)Wtsi |
HET | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
7.89×10-05 | |
F2 F2tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
8.46×10-05 |